Non-high-density-lipoprotein (HDL) cholesterol in Algerian hemodialysis patients

Shojie, 2006, Plasma lipoprotein abnormalities in hemodialysis patients: clinical implications and therapeutic guidelines, Ther Apher Dial, 10, 305, 10.1111/j.1744-9987.2006.00382.x Schreier, 2004, Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients, Metabolism, 53, 1013, 10.1016/j.metabol.2004.01.001 Executive summary of the third report of the National cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001; 285: 2486–97. Noda, 2010, Association between non-high-density lipoprotein cholesterol concentrations and mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study, J Atheroscler Thromb, 17, 30, 10.5551/jat.1016 Li, 2011, Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study, Cardiovasc Diabetol, 10, 46, 10.1186/1475-2840-10-46 Chapman, 2004, Non-high-density lipoprotein cholesterol as a risk factor: addressing risk associated with apolipoprotein B containing lipoproteins, Eur Heart J, 6, A43, 10.1016/j.ehjsup.2004.01.010 Rallidisa, 2005, Non-high density lipoprotein cholesterol is the best discriminator of myocardial infarction in young individuals, Atherosclerosis, 179, 305, 10.1016/j.atherosclerosis.2004.09.022 National Kidney Foundation, 2003, K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease, Am J Kidney Dis, 41, S1 Iseki, 2003, Effect of duration of dialysis on survival in a cohort of chronic haemodialysis patients, Nephrol Dial Transplant, 18, 782, 10.1093/ndt/gfg145 Tsimihodimos, 2008, Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment, Am J Nephrol, 28, 958, 10.1159/000144024 Lee, 2002, Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency, Kidney Int, 61, 209, 10.1046/j.1523-1755.2002.00116.x Wanner, 2003, Non-HDL cholesterol: a target of lipidlowering in dialysis patients, Am J Kidney Dis, 41, S72, 10.1053/ajkd.2003.50089 Lacquaniti, 2010, Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment, Kidney Blood Press Res, 33, 100, 10.1159/000302712 Blankestijn, 1995, High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients, J Am Soc Nephrol, 5, 1703, 10.1681/ASN.V591703 Näsström, 2005, A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing, Nephrol Dial Transplant, 20, 1172, 10.1093/ndt/gfh774 Shoji, 2011, Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients, Clin J Am Soc Nephrol, 6, 1112, 10.2215/CJN.09961110 Nishizawa, 2003, Non-highdensity lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease, Kidney Int Suppl, 84, S117, 10.1046/j.1523-1755.63.s84.30.x Shoji, 1998, Intermediate density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients, J Am Soc Nephrol, 9, 1277, 10.1681/ASN.V971277